Inventiva and Hepalys Pharma, Inc. announce exclusive licensing agreement to develop and commercialize lanifibranor in Japan and South Korea

Essential for the website to function (navigation, security, session). They cannot be disabled.

Improve usability: remembering language, region and your preferences.

Help us understand how the site is used (page views, audience) to optimise it.

Allow relevant advertising to be shown and campaigns to be measured.